# Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma

> **NCT04385173** · PHASE1 · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 12 (estimated)

## Conditions studied

- Recurrent Glioblastoma
- Refractory Glioblastoma

## Interventions

- **DRUG:** B7-H3 CAR-T
- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT04385173
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2022-12-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04385173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04385173, "Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04385173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*